Table 3.

The Effect of GPx Inhibitor and Catalase Inhibitor on As2O3-Induced Apoptosis in NB4, HL-60, and U937 Cells

Treatment Apoptotic Cells (%)
NB4 HL60 U937
Control  2.0 ± 0.8 2.5 ± 0.4  2.3 ± 0.7  
As2O3 9.0 ± 3.1  2.5 ± 0.6  1.4 ± 0.3  
MS 6.0 ± 2.4  11.4 ± 1.3  7.3 ± 1.4 
MS + As2O3 47.0 ± 6.7 39.0 ± 3.7  43.4 ± 5.9  
AT  24.0 ± 8.3 15.4 ± 2.9  6.3 ± 3.1 
AT + As2O3 49.0 ± 3.8 27.2 ± 5.6  20.5 ± 1.3 
Treatment Apoptotic Cells (%)
NB4 HL60 U937
Control  2.0 ± 0.8 2.5 ± 0.4  2.3 ± 0.7  
As2O3 9.0 ± 3.1  2.5 ± 0.6  1.4 ± 0.3  
MS 6.0 ± 2.4  11.4 ± 1.3  7.3 ± 1.4 
MS + As2O3 47.0 ± 6.7 39.0 ± 3.7  43.4 ± 5.9  
AT  24.0 ± 8.3 15.4 ± 2.9  6.3 ± 3.1 
AT + As2O3 49.0 ± 3.8 27.2 ± 5.6  20.5 ± 1.3 

NB4 cells were treated with 0.5 μmol/L As2O3 alone or plus 100 μmol/L MS or 20 mmol/L AT for 3 days; HL-60 cells were treated with 1 μmol/L As2O3 alone or plus 25 μmol/L MS or 20 mmol/L AT for 3 days; U937 cells were treated with 1 μmol/L As2O3 alone or plus 100 μmol/L MS or 20 mmol/L AT for 3 days. Each value is the mean ± SD of triplicate determinations.

Close Modal

or Create an Account

Close Modal
Close Modal